Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4771 to 4785 of 7691 results

  1. Further research on unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease, which could include randomised controlled trials, should address patient selection and report on long-term follow-up.

    Recommendation ID IPG606/1 Question Further research on unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor

  2. Further research, preferably in the form of randomised controlled trials, should assess the effect of the procedure on local tumour control, patient survival, paincontrol and quality of life.

    Recommendation ID IPG579/1 Question Further research, preferably in the form of randomised controlled trials, should assess the effect

  3. Further research should include details of patient selection and report longer term outcomes.

    Recommendation ID IPG777 Question Further research should include details of patient selection and report longer term outcomes. Any

  4. Further research should include details of patient selection, durability and the incidence of complications. Outcomes should be published.

    Recommendation ID IPG642/1 Question Further research should include details of patient selection, durability and the incidence of complications

  5. Further research should report:

    Recommendation ID IPG773 Question Further research should report: Any explanatory notes(if applicable) details of patient

  6. Further research should report details of patient selection, duration of the effect (including whether repeat procedures are needed), and long term outcomes.

    Recommendation ID IPG771 Question Further research should report details of patient selection, duration of the effect (including whether

  7. Further research should report details of patient selection, nodule size and position, and whether the nodule is cystic.

    Recommendation ID IPG643/1 Question Further research should report details of patient selection, nodule size and position, and whether

  8. Further studies on the clinical effectiveness of mifamurtide when combined with the chemotherapy typical of UK clinical practice would be useful to determine the size of the effect of mifamurtide.

    Recommendation ID TA235/1 Question Further studies on the clinical effectiveness of mifamurtide when combined with the chemotherapy typical

  9. Further evidence to address the uncertainties in the current clinical evidence,including the impact of gammaCore on all treatments and care as well as itslong-term benefits, would be welcome.

    Recommendation ID MTG46/1 Question Further evidence to address the uncertainties in the current clinical evidence,including the impact

  10. What specialist management is effective for people whose symptoms do not respond to PPIs despite optimum primary care, or for people whose symptoms return after surgery?

    Recommendation ID CG184/4 Question What specialist management is effective for people whose symptoms do not respond to PPIs despite optimum

  11. What is the most effective management strategy for preventing the development of excessive weight gain and metabolic syndrome associated with the use of antipsychotic medication in children and young people?

    Recommendation ID CG155/6 Question What is the most effective management strategy for preventing the development of excessive weight gain

  12. What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic medication and compared with psychological intervention and antipsychotic medication combined, in young people with first episode psychosis?

    Recommendation ID CG155/4 Question What is the clinical and cost effectiveness of psychological intervention alone, compared with antipsychotic